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Objectives. This study examined the effect of endocardial and
transthoracic direct current (DC) shocks on left atrial and left
atrial appendage function in humans with structural heart dis-
ease.
Background. DC cardioversion of atrial fibrillation (AF) to
sinus rhythm is associated with transient left atrial and left atrial
appendage dysfunction and the development of spontaneous echo
contrast (SEC). This phenomenon has been termed atrial “stun-
ning” and may be associated with thrombus formation and
embolic stroke. To what extent the shock itself contributes to
atrial stunning is unclear.
Methods. Thirteen patients in sinus rhythm undergoing im-
plantation of a ventricular implantable cardioverter defibrillator
(ICD) were prospectively evaluated. All patients had significant
structural heart disease. To evaluate the effects of DC shocks on
left atrial and left atrial appendage function, biphasic R wave
synchronized endocardial shocks of 1, 10 and 20 J were delivered
between the right ventricular electrode and the left pectoral
generator of the ICD in sinus rhythm. R wave synchronized
transthoracic shocks of 360 J were also delivered between anteri-
orly and posteriorly positioned chest electrodes. Transesophageal
echocardiography was performed to evaluate left atrial appendage
velocities, mitral inflow velocities and the presence of SEC before
and immediately after each DC shock.
Results. There were no significant changes in left atrial or left
atrial appendage function after endocardial or transthoracic DC
shocks. Left atrial SEC did not develop after endocardial or
transthoracic DC shocks.
Conclusions. Endocardial and transthoracic DC shocks are not
directly responsible for left atrial and left atrial appendage
stunning and do not contribute to the stunning that is observed
after the cardioversion of AF to sinus rhythm.
(J Am Coll Cardiol 1998;31:1395–9)
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Cardioversion of atrial fibrillation (AF) to sinus rhythm is
associated with transient mechanical dysfunction of the left
atrium and left atrial appendage and the development of
spontaneous echo contrast (SEC) (1–3). This phenomenon has
been termed “stunning” and appears to develop after both
electrical and pharmacologic cardioversion of AF to sinus
rhythm (4,5). There is considerable evidence to suggest that
left atrial and left atrial appendage stunning is responsible for
the increased risk of thromboembolic stroke after cardiover-
sion of AF to sinus rhythm that may occur hours to weeks after
cardioversion (2,6). The exact mechanism underlying the de-
velopment of atrial stunning remains unknown. There is
evidence to suggest that direct current (DC) shocks lead to
considerable myocardial damage at both a biochemical and
histologic level and that the shock itself may contribute to
atrial stunning (2–4,7–11). Other evidence suggests that it is
the arrhythmia itself that is responsible for the postreversion
mechanical dysfunction rather than the method of reversion
(1,12).
The concept of mechanical dysfunction after cardioversion
of AF is well established. To evaluate the contribution of DC
shocks to the mechanism of atrial stunning, we assessed the
effects of endocardial and transthoracic DC shocks on left
atrial and left atrial appendage function in patients in sinus
rhythm.
Methods
Patients. Thirteen patients in sinus rhythm undergoing
implantation of a ventricular implantable cardioverter-
defibrillator (ICD) for accepted indications were recruited. All
patients gave written informed consent to participate in the
study, which was approved by the Board of Medical Research
of the Royal Melbourne Hospital. All patients underwent
transthoracic echocardiography and gated blood pool scanning
to evaluate left atrial size and left ventricular function before
ICD implantation.
ICD implantation procedure. A standardized general an-
esthetic was given to all patients and consisted of propofol
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induction followed by anesthesia maintained with the volatile
agent isoflurane and the muscle relaxant atracurium. All
devices were implanted in the left prepectoral position with the
ventricular endocardial leads placed at the right ventricular
apex.
ICD shock vector, waveform and DC shock delivery. All
endocardial shocks were delivered between the right ventricu-
lar cathode and the ICD generator anode. After endocardial
lead placement and ICD insertion, a standardized series of
endocardial DC shocks were delivered with transesophageal
echocardiographic (TEE) assessment of left atrial and left
atrial appendage function performed before and after each
shock. All shocks were delivered in sinus rhythm and were
synchronized to the R wave of the intrinsic QRS complex.
Shock energy, synchronization and delivery were controlled
through telemetry of the ICD system. Biphasic endocardial
shocks of 1, 10 and 20 J were delivered, followed by immediate
echocardiographic assessment. A 5-min interval separated
each shock. Formal testing of the ICD was then performed
with induction of ventricular fibrillation (VF) and assessment
of endocardial defibrillation thresholds. After each DC shock
reversion of VF, another echocardiographic assessment of left
atrial and left atrial appendage function was made.
After satisfactory testing and programming of the ICD, a
transthoracic DC shock of 360 J synchronized to the R wave
was delivered in sinus rhythm, and a further assessment of left
atrial and left atrial appendage function was made. Trans-
thoracic shocks were delivered through anteriorly and poste-
riorly positioned adhesive patches (Physio-Control Fast-Patch,
Physio-Control Corporation) with a combined surface area of
;150 cm2 connected to an external DC defibrillator (Physio-
Control Lifepak 8).
Echocardiographic analysis. Left atrial and left atrial ap-
pendage function were assessed before the first shock delivery
and immediately after each endocardial or transthoracic shock.
Recordings were performed during apnea to minimize poten-
tial velocity variations caused by mechanical ventilation. TEE
was performed using a 5-MHz phased array multiplane probe
connected to a Hewlett-Packard Sonos 2500 ultrasound sys-
tem. Images were recorded on 0.5-in. super-VHS tape and
analyzed off-line using Hewlett-Packard software. All velocity
measurements were performed off-line and averaged over 20
cardiac cycles.
Left atrial appendage emptying velocities were assessed
using pulsed wave Doppler, with the sample volume placed
1 cm into the mouth of the left atrial appendage. A multiplane
probe was used to scan the appendage from 0° to 130° in the
transverse plane to establish an angle at which maximal flow
velocities could be obtained. This angle was retained for
subsequent analysis. Left atrial function was assessed with TEE
pulsed wave Doppler interrogation of the mitral inflow E and
A waves, with the sample volume placed at the level of the
mitral valve leaflet tips.
SEC was defined as swirling patterns of echogenicity in the
left atrium and left atrial appendage distinct from white noise
artifact. Gain settings were reduced in a sequential manner to
distinguish echo contrast from noise artifact and were main-
tained for the duration of the study. Two experienced echo-
cardiographers (J.K., A.Y.) analyzed the preshock and post-
shock images for SEC. Analysis was performed off-line, and
each echocardiographer had no knowledge of other’s interpre-
tations.
Statistical analysis. Results are presented as mean value 6
SD. A repeated measures analysis of variance was used to
analyze Doppler velocities. A p value ,0.05 was considered
significant. The study was designed with 95% power to detect
a mean fall in left atrial appendage velocity of 14 6 13 cm/s (1).
Using a two-tailed test, the required number of patients was 12
(13).
Results
Patients. The study included 13 consecutive patients un-
dergoing implantation of an ICD for accepted indications. All
patients were either survivors of resuscitated sudden cardiac
death or had rapid ventricular tachycardia or VF at electro-
physiologic study. All patients had significant structural heart
disease with left ventricular dysfunction (mean left ventricular
ejection fraction 28.2 6 12.7%). Left atrial enlargement was
present in all patients (5.3 6 0.4 cm), and mitral regurgitation
ranged from severe to trivial, with a mean grade of 1.2 6 1.0
Table 1. Clinical and Echocardiographic Characteristics of 13
Patients Undergoing Implantable Cardioverter-Defibrillator
Implantation and Direct Current Shocks in Sinus Rhythm
Age (yr) 55.7 6 11.3
Male/female 10/3
History of AF 1
Ischemic cardiomyopathy 7
Dilated cardiomyopathy 4
Mitral valve prolapse 2
LVEF (%) 28.2 6 12.7
LA size (cm) 5.3 6 0.4
LVESD (cm) 5.7 6 0.9
LVEDD (cm) 7.3 6 0.6
LVFS (%) 22.6 6 7.9
Drug therapy
Amiodarone 9
Sotalol 4
Data presented are mean value 6 SD or number of patients. AF 5 atrial
fibrillation; LA 5 left atrial; LVEDD 5 left ventricular end-diastolic diameter;
LVEF 5 left ventricular ejection fraction; LVESD 5 left ventricular end-systolic
diameter; LVFS 5 left ventricular fractional shortening.
Abbreviations and Acronyms
AF 5 atrial fibrillation
DC 5 direct current
ICD 5 implantable cardioverter-defibrillator
SEC 5 spontaneous echo contrast
TEE 5 transesophageal echocardiography (echocardiographic)
VF 5 ventricular fibrillation
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(Table 1). Nine patients (69%) were taking amiodarone, and 4
(31%) were taking sotalol for ventricular arrhythmias.
Left atrial and left atrial appendage function before shock
(Fig. 1 and 2). Mean left atrial appendage velocity for the
patients was 45.0 6 25.6 cm/s. Preshock transmitral A wave
velocity was 42.6 6 14.2 cm/s, and the E wave velocity was
63.0 6 12.5 cm/s (Table 2). SEC was absent in all patients
before shock delivery.
Left atrial and left atrial appendage function after shock.
There were no significant changes in transmitral A wave
velocities or left atrial appendage velocities compared with
preshock baseline values after endocardial DC shock delivery
at 1, 10 and 20 J and after external DC shock delivery at 360 J
(Table 2). There was no evidence of left atrial stunning caused
by endocardial or external shocks delivered in sinus rhythm.
Mean sinus rates after endocardial and external shock delivery
were not significantly different from baseline values (Table 2).
Mean endocardial defibrillation energy delivered for VF was
20.5 6 5.3 J (range 15 to 34 J). After induction of VF and
successful endocardial DC shock reversion, left atrial and left
atrial appendage function were again similar to preshock
values.
Left atrial SEC. No patient developed left atrial or left
atrial appendage SEC after endocardial or external DC shocks
delivered in sinus rhythm. Left atrial SEC developed in all
patients after induction of VF and cleared rapidly with re-
sumption of coordinated ventricular contraction and effective
left atrial emptying after successful ventricular defibrillation.
Discussion
New findings. Transient left atrial and left atrial append-
age dysfunction or “stunning” is considered an important
mechanism responsible for the development of late thrombo-
embolism occurring hours to weeks after cardioversion of AF
to sinus rhythm (2,3,14). This concept is based largely on the
significant changes in left atrial and left atrial appendage flow
that develop after cardioversion of AF to sinus rhythm.
Decreased late mitral inflow velocities and reduced left atrial
appendage velocities after cardioversion correlate strongly
with the development of left atrial SEC, which occurs com-
monly with left atrial appendage thrombosis and the develop-
ment of late thromboembolic stroke (2).
The findings of the present study challenge the concept that
atrial stunning is due in part to the electrical energy delivered
at the time of cardioversion. We demonstrated that after both
endocardial and externally delivered shocks, left atrial and left
atrial appendage function were not significantly affected, and
the phenomenon of stunning did not occur. Indeed, there was
no alteration in mechanical function associated with the cu-
mulative effects of these sequential shocks. This was shown in
a group of patients with structural heart disease who might
reasonably be considered similar to patients undergoing car-
dioversion of AF to sinus rhythm.
Comparison with previous studies. Previous studies of
atrial stunning have been performed in patients with AF and
atrial flutter and have demonstrated that both low energy
internal and higher energy external defibrillation may be
associated with depression of left atrial function (1–3,15).
Whether the shock itself is of importance in producing atrial
stunning has not been studied in detail.
Fatkin et al. (2) demonstrated an association between the
number and energy level of DC shocks delivered in AF and the
development of SEC with reversion to sinus rhythm. These
investigators suggested that the DC shock contributed to the
mechanism of atrial stunning. An alternative explanation may
Figure 1. Mean left atrial appendage emptying
velocities, with standard errors indicated.
LAAeV 5 left atrial appendage emptying veloc-
ity.
Figure 2. Mean mitral A wave velocities, with standard
errors indicated. MVA 5 mitral valve A wave.
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be that patients requiring more and higher energy shocks for
cardioversion have longer duration AF and more advanced
atrial disease, thus predisposing them to the atrial stunning
that occurs on termination of the arrhythmia.
Conversely, Falcone et al. (16) examined the effect of
ineffective external shocks on left atrial appendage function in
patients with AF during attempts at cardioversion to sinus
rhythm. Left atrial appendage function in AF did not change
appreciably after noncardioverting external DC shocks of 50 to
100 J. The effects of more powerful external shocks on left
atrial function and the effects of internally and externally
applied energy on left atrial function in sinus rhythm were not
examined.
In contrast to studies in which cardioverting DC shocks
were delivered during AF, all patients in the present study
were in sinus rhythm at the time of DC shock delivery. This
approach permitted independent evaluation of the effect of
DC current on atrial function in the absence of an effect of
cardioversion itself. To enhance the possibility for atrial stun-
ning, we specifically selected a group of patients with signifi-
cant structural heart disease and atrial dilation (14,17). In
addition, all patients were taking antiarrhythmic drugs, such as
sotalol, which also exacerbates atrial stunning after DC cardio-
version (5). Despite this potent combination of factors, stun-
ning was not observed after DC shocks delivered in sinus
rhythm.
The present study also demonstrated that left atrial and left
atrial appendage SEC develops during VF but clears almost
immediately after resumption of coordinated ventricular con-
traction after successful ventricular defibrillation. SEC in this
circumstance is not a consequence of left atrial stunning but a
consequence of ineffective left atrial emptying into the fibril-
lating ventricle.
Clinical implications. The present study demonstrated
that DC shocks do not contribute to atrial stunning. This
finding suggests that the stunning observed after cardioversion
of AF is mediated by the preceding arrhythmia itself. Although
the major aim of the study related to the mechanism of
stunning, if our observations also hold true for the fibrillating
atrium, there may be several clinical implications:
1. Spontaneous or chemical reversion of AF to sinus
rhythm is unlikely to be associated with less atrial stunning
than that seen after DC cardioversion. All patients reverting to
sinus rhythm from AF should therefore be considered for
prophylactic anticoagulation regardless of the mode of rever-
sion. The decision for anticoagulation may also depend on the
chronicity of AF and the existing atrial pathologic features.
2. The efficacy of low energy endocardial defibrillation for
AF has been demonstrated, and a multicenter study examining
the feasibility of an implanted atrial defibrillator is in progress.
Data demonstrate that cardioversion with ,5 J can be success-
ful in the majority of patients with paroxysmal forms of AF
(18). Our study demonstrates that patients with an implanted
atrial defibrillator are not at risk for developing atrial mechan-
ical dysfunction (and hence thromboembolism) as a result of
the shock itself. Whether short-duration AF is sufficient to
produce atrial stunning is still uncertain.
Implications for ICD recipients. Recent evidence (19)
suggests a significant incidence of stroke after ICD discharge
for ventricular arrhythmias in patients with chronic AF. Re-
version of AF in these circumstances presumably results in
atrial stunning. The current study suggests that endocardial
shocks delivered during sinus rhythm do not cause atrial
stunning and that ventricular ICD recipients in sinus rhythm
are not at an increased risk for stroke after defibrillation
therapy.
Limitations of the study. All shocks were delivered to atria
in sinus rhythm rather than during fibrillation, and our obser-
vations may therefore not necessarily be applicable to patients
with AF. It is conceivable that a fibrillating atrium is more
sensitive to the effects of DC current than an atrium in sinus
rhythm. Nevertheless, all patients in our study had structural
heart disease, atrial dilation and baseline appendage velocities
lower than previously reported normal values and were similar
to patients with AF who might be considered candidates for
DC cardioversion (20). No further depression of function after
repeated sequential shocks to these atria is strong evidence
that DC shocks do not contribute to stunning.
The endocardial shock vector differs from the coronary
sinus–right atrium vector that is commonly used for internal
defibrillation of AF (18). However, the active pectoral device
cathode–right ventricular anode configuration is effective in
reverting AF to sinus rhythm (19,21). High energy external
shocks were also delivered without causing atrial stunning. It is
unlikely that ineffective, nondefibrillating energy levels were
delivered and that the lack of stunning observed was simply a
function of low incident energy or a poorly positioned shock
vector.
Table 2. Doppler Blood Flow Velocity Measurements and Sinus Rate Before and After Endocardial
Direct Current Shocks in Sinus Rhythm and Ventricular Fibrillation and Transthoracic 360-J Shocks in
Sinus Rhythm in 13 Patients
Before Shock 1 J 10 J 20 J VF 15–34 J 360 J p Value
LAAeV (cm/s) 45.0 6 26.6 45.5 6 25.6 44.4 6 23.7 45.9 6 24.7 48.8 6 25.6 47.6 6 22.0 0.99
MVA (cm/s) 42.6 6 14.2 41.3 6 16.7 43.7 6 13.6 43.5 6 14.6 47.7 6 17.4 46.9 6 17.0 0.90
MVE (cm/s) 63.0 6 12.5 62.6 6 14.2 67.6 6 10.2 65.3 6 10.8 68.7 6 11.3 66.7 6 11.7 0.70
HR (beats/min) 63 6 14 61 6 14 64 6 13 66 6 14 67 6 13 68 6 13 0.90
Data presented are mean value 6 SD. HR 5 heart rate; LAAeV 5 left atrial appendage emptying velocity; MVA 5
mitral valve A wave velocity; MVE 5 mitral valve E wave velocity; VF 5 ventricular fibrillation.
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Conclusions. The present study provides additional infor-
mation regarding the mechanisms responsible for atrial stun-
ning after cardioversion of AF to sinus rhythm. Endocardial
and external DC shocks did not cause atrial stunning, suggest-
ing that DC shocks may not be a contributing mechanism to
the stunning that is observed after cardioversion of AF to sinus
rhythm. This finding has potentially important implications
for recipients of an implanted atrial defibrillator. The
present study has added support to the notion that atrial
stunning after reversion from AF to sinus rhythm is a
function of the preceding arrhythmia itself rather than the
mode of reversion.
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